Transverse myelopathy is a rare complication of systemic lupus erythematosus, and the prognosis is generally poor. ' Although it has been suggested that steroids confer no benefit,2 there are several reports of complete or partial recovery associated with high dose steroid treatment. We describe a patient with transverse myelopathy associated with systemic lupus erythematosus treated, uniquely, with steroids, cyclophosphamide, and plasma exchange. Moreover, we review the published work concerning the treatment and prognosis of this condition, and the usual cerebrospinal fluid findings. Although it has been suggested that steroids are ineffective in transverse myelopathy due to systemic lupus erythematosus,2 this review suggests that significant benefit may be gained from their early administration. Furthermore, the published work contains a further four cases where high dose steroids were administered with subsequent improve- [25] [26] [27] iin ment in neurological function, but as insufficient detail was given in these reports they are not included in this review. We can only postulate the mode of action of high dose steroids in this condition. Vasculitis is a prominent feature in the spinal cord at postmortem examination ' which suggests that steroids may act by suppressing the vasculitic process. If this is the case then plasma exchange is a logical treatment as it may reduce 
